Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MRSA Bacteremia”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Testing effectiveness (Phase 2)Ended earlyNCT05225558
What this trial is testing

A Phase 2a Study, Effect of Vancomycin With vs Without Delpazolid (LCB01-0371) in Patients With MRSA Bacteremia

Who this might be right for
MRSA Bacteremia
LigaChem Biosciences, Inc. 40
Post-approval studies (Phase 4)Enrolling By InvitationNCT07148960
What this trial is testing

Does Staphylococcus Aureus Bacteremia Early Dual Therapy Improve Outcomes?

Who this might be right for
Staphylococcus Aureus Bacteremia
West Virginia University 300
Testing effectiveness (Phase 2)Study completedNCT03643952
What this trial is testing

Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029)

Who this might be right for
BacteremiaSoft Tissue InfectionsSkin Diseases, Infectious
Merck Sharp & Dohme LLC 18
Not applicableStudy completedNCT00448942
What this trial is testing

The Impact of Chlorhexidine-Based Bathing on Nosocomial Infections

Who this might be right for
Nosocomial BacteremiaNosocomial FungemiaMRSA Colonization+3 more
Hunter Holmes Mcguire Veteran Affairs Medical Center 5,300
Not applicableStudy completedNCT06069206
What this trial is testing

Effect of Direct-from-blood Bacterial Testing on Antibiotic Administration and Clinical Outcomes

Who this might be right for
Bloodstream InfectionSepsis BacterialMRSA Bacteremia+1 more
Vanderbilt University Medical Center 500
Not applicableStudy completedNCT01898208
What this trial is testing

Rapid Identification and Susceptibility Testing of Pathogens From Blood Cultures

Who this might be right for
BacteremiaFungemiaBloodstream Infection
Mayo Clinic 743
Not applicableUnknownNCT01352936
What this trial is testing

Comparison of Nephrotoxicity and Hospital Costs in Patients With Methicillin-Resistant Staphylococcus Aureus Bacteremia Who Received Vancomycin Versus Teicoplanin Therapy

Who this might be right for
Staphylococcus AureusBacteremia
Taipei Medical University WanFang Hospital 190
Not applicableUnknownNCT01724671
What this trial is testing

Vancomycin Versus Ceftaroline in Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline

Who this might be right for
MRSA InfectionBacteremiaABSSSI+1 more
CPL Associates 30
Large-scale testing (Phase 3)Ended earlyNCT01515020
What this trial is testing

Daptomycin Versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated MRSA Bacteremia

Who this might be right for
Nosocomial InfectionHealthcare-associated Infection
Assistance Publique - Hôpitaux de Paris 10
Post-approval studies (Phase 4)Study completedNCT01701219
What this trial is testing

Safety and Efficacy Study of Ceftaroline in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia

Who this might be right for
Staphylococcus Aureus BacteremiaMethicillin-resistant Staphylococcus Aureus (MRSA) Bacteremia
Forest Laboratories 56
Large-scale testing (Phase 3)Study completedNCT00427076
What this trial is testing

Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus Infections

Who this might be right for
Staphylococcal InfectionsMeningitisSepsis+1 more
Rabin Medical Center 252
Testing effectiveness (Phase 2)Ended earlyNCT03089697
What this trial is testing

Phase IIa Clinical Study of N-Rephasin® SAL200

Who this might be right for
Staphylococcus Aureus BacteremiaAnti-Bacterial Agents
Intron Biotechnology, Inc. 25
Post-approval studies (Phase 4)Ended earlyNCT00638157
What this trial is testing

Phase 4 Efficacy and Safety Study of Cubicin® With and Without Combination Therapy in S. Aureus Infective Endocarditis (SAIE)

Who this might be right for
Infective Endocarditis
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 24
Testing effectiveness (Phase 2)Ended earlyNCT00695903
What this trial is testing

Phase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA Bacteremia

Who this might be right for
Endocarditis, BacterialInfective Endocarditis
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 38
Large-scale testing (Phase 3)Study completedNCT01967225
What this trial is testing

Safety and Efficacy of BAY1192631 in Japanese Patients With Methicillin-resistant Staphylococcus Aureus (MRSA) Infections

Who this might be right for
Skin Diseases, Infectious
Bayer 125
Testing effectiveness (Phase 2)WithdrawnNCT00505258
What this trial is testing

Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia

Who this might be right for
Bacteremia
Basilea Pharmaceutica
Not applicableStudy completedNCT01184339
What this trial is testing

Prospective Study Into the Performance of the MicroPhage S. Aureus/MSSA/MRSA Test Direct From Blood Culture Positives

Who this might be right for
Bacteremia
MicroPhage, Inc. 1,165
Not applicableStudy completedNCT03096405
What this trial is testing

Impact MRSA -PCR on Patient Management

Who this might be right for
MRSA Bacteremia
Fondation Hôpital Saint-Joseph 50
Large-scale testing (Phase 3)Study completedNCT01898338
What this trial is testing

Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin for Treatment of MRSA Bacteremia

Who this might be right for
Staph Aureus Methicillin Resistant Bacteremia
Miquel Pujol 167
Post-approval studies (Phase 4)Study completedNCT02660346
What this trial is testing

IL-10 Stratifying Tool for Towards Antibiotic Selection for MRSaB

Who this might be right for
Bacteremia
Sharp HealthCare 40
Next Page